Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Haemophilus influenzae type B
Pneumococcal disease
Rubella
Systematic reviews (SYSVAC)
2019
Clear all
Type of publications
NITAG documentation
(10)
SAGE documentation
(1)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(14)
Topics
Available to download in languages
Regions
Africa
(1)
Americas
(1)
Europe
(1)
South-East Asia
(1)
Western Pacific
(2)
Countries
Diseases
Haemophilus influenzae type B
(1)
Pneumococcal disease
(10)
Rubella
(3)
Dengue
(3)
Diphtheria
(4)
Hepatitis A
(1)
Hepatitis B
(6)
Herpes zoster
(4)
HIV / AIDS
(1)
Influenza
(18)
Measles
(7)
Mumps
(3)
Pertussis
(8)
Poliomyelitis
(6)
Rabies
(1)
Rotavirus
(2)
Tetanus
(4)
Tuberculosis
(5)
Varicella
(2)
Vaccine topics
Acceptance
(2)
Administration
(5)
Coverage
(5)
Economic aspects
(2)
Efficacy/effectiveness
(9)
Safety
(5)
Target population
Adolescents
(1)
Adults
(4)
All age groups
(3)
Children
(5)
Healthcare workers
(1)
Newborn
(7)
Older adults
(3)
Publication date
2019
(14)
2023
(16)
2022
(27)
2021
(15)
2020
(15)
2018
(7)
2017
(20)
2016
(27)
2014
(11)
2013
(11)
2012
(12)
2011
(5)
14 results found
2019
∙
McGirr, A. Iqbal, S. M. Izurieta, P. Talarico, C. Luijken, J. Redig, J. Newson, R. S.
A systematic literature review and network meta-analysis feasibility study to assess the comparative efficacy and comparative effectiveness of pneumococcal conjugate vaccines
2019
∙
Walker, E. J. MacDonald, N. E. Islam, N. Le Saux, N. Top, K. A. Fell, D. B.
Completeness and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and polio vaccines in young children with chronic health conditions: A systematic review
2019
∙
Leidner, A. J. Murthy, N. Chesson, H. W. Biggerstaff, M. Stoecker, C. Harris, A. M. Acosta, A. Dooling, K. Bridges, C. B.
Cost-effectiveness of adult vaccinations: A systematic review
2019
∙
Sings, H. L. De Wals, P. Gessner, B. D. Isturiz, R. Laferriere, C. McLaughlin, J. M. Pelton, S. Schmitt, H. J. Suaya, J. A. Jodar, L.
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies
2019
∙
Vardanjani, H. M. Borna, H. Ahmadi, A.
Effectiveness of pneumococcal conjugate vaccination against invasive pneumococcal disease among children with and those without HIV infection: a systematic review and meta-analysis
2019
∙
Ngocho, J. S. Magoma, B. Olomi, G. A. Mahande, M. J. Msuya, S. E. de Jonge, M. I. Mmbaga, B. T.
Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review
2019
∙
Adawi, M. Bragazzi, N. L. McGonagle, D. Watad, S. Mahroum, N. Damiani, G. Conic, R. Bridgewood, C. Mahagna, H. Giacomelli, L. Eggenhoffner, R. Mahamid, M. Pigatto, P. D. M. Amital, H. Watad, A.
Immunogenicity, safety and tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus patients: An evidence-informed and PRISMA compliant systematic review and meta-analysis
2019
∙
Vadlamudi, N. K. Chen, A. Marra, F.
Impact of the 13-Valent Pneumococcal Conjugate Vaccine Among Adults: A Systematic Review and Meta-analysis
2019
∙
Dolhain, J. Janssens, W. Sohn, W. Y. Dindore, V. Mukherjee, P.
Integration of hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine within existing national recommendations following a birth dose of monovalent hepatitis B virus vaccine: results of a systematic review in the Asia Pacific region
2019
∙
McLaughlin, J. M. Jiang, Q. Gessner, B. D. Swerdlow, D. L. Sings, H. L. Isturiz, R. E. Jodar, L.
Pneumococcal conjugate vaccine against serotype 3 pneumococcal pneumonia in adults: A systematic review and pooled analysis
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register